Setup of Aerosol Delivery System to Prevent Measles Virus Infection in Nonhuman Primate Model
Author:
Reynard OlivierORCID,
Montharu Jérôme,
Iampietro Mathieu,
Gonzalez Claudia,
Le Guellec Sandrine,
Horvat Branka,
Vecellio Laurent
Reference9 articles.
1. Anderson RM, May RM (1982) Directly transmitted infections diseases: control by vaccination. Science 215:1053–1060. https://doi.org/10.1126/science.7063839
2. Figueira TN, Palermo LM, Veiga AS, Huey D, Alabi CA, Santos NC, Welsch JC, Mathieu C, Horvat B, Niewiesk S, Moscona A, Castanho MARB, Porotto M (2017) In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence. J Virol 91:e01554–e01516. https://doi.org/10.1128/JVI.01554-16
3. Harrison SC (2008) Viral membrane fusion. Nat Struct Mol Biol 15:690–698. https://doi.org/10.1038/nsmb.1456
4. Martin AR, Finlay WH (2015) Nebulizers for drug delivery to the lungs. Expert Opin Drug Deliv 12:889–900. https://doi.org/10.1517/17425247.2015.995087
5. Mathieu C, Huey D, Jurgens E, Welsch JC, DeVito I, Talekar A, Horvat B, Niewiesk S, Moscona A, Porotto M (2015) Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides. J Virol 89:1143–1155. https://doi.org/10.1128/JVI.02417-14